Richard G. Langley
Dalhousie University(CA)University of Auckland(NZ)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Asthma and respiratory diseases, Autoimmune Bullous Skin Diseases, Pharmaceutical studies and practices
Most-Cited Works
- → Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials(2014)1,933 cited
- → Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)(2008)1,344 cited
- → Psoriasis: epidemiology, clinical features, and quality of life(2005)1,094 cited
- → Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial(2007)872 cited
- → Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis(2016)822 cited
- → Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis(2015)792 cited
- →